Sulodexide Improves Long Covid

Sulodexide Improves Long Covid
Aug 4, 2022 1:54pm

Here is a breakthrough study from Tunisia indicating the efficacy of sulodexide [Aterina], the oral "fast-moving heparin"-dermatan sulfate formulation, in managing the endothelial dysfunction of and reducing the symptoms associated with Long Covid. Sulodexide is not FDA-approved for Long Covid therapy.

Charfeddine S, Ibnhadjamor H, Jdidi J, et al. Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with Long-COVID-19: insights from TUN-EndCOV study. Front. Cardiovasc. Med. 2022, 9:866113. doi: 10.3389/fcvm.2022.866113.

This article cites current guidelines for Long Covid management:

Shah S, Hillman T, Playford D, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 202; 372:n136 | doi: 10.1136/bmj.n136

0 Comments

Here is a breakthrough study from Tunisia indicating the efficacy of sulodexide [Aterina], the oral "fast-moving heparin"-dermatan sulfate formulation, in managing the endothelial dysfunction of and reducing the symptoms associated with Long Covid. Sulodexide is not FDA-approved for Long Covid therapy.

Charfeddine S, Ibnhadjamor H, Jdidi J, et al. Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with Long-COVID-19: insights from TUN-EndCOV study. Front. Cardiovasc. Med. 2022, 9:866113. doi: 10.3389/fcvm.2022.866113.

This article cites current guidelines for Long Covid management:

Shah S, Hillman T, Playford D, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 202; 372:n136 | doi: 10.1136/bmj.n136

Leave A Comment

You must be logged in to Comment - Sign In